https://www.insidetechlaw.com/blog/rss/life-sciences-and-healthcareRecent blog postsen{73674ADE-AEC2-4777-BD2E-D0EE205B1458}https://www.insidetechlaw.com/blog/2026/04/tech-in-healthcare-key-trends-for-2026Roger KuanEbony ChristianApurv GauravNathanael Herz Green, PhDJason NovakSophia PoirierArtificial intelligenceTech regulation insightsLife sciences and healthcareBlog postNorton Rose Fulbright lawyers authored and edited key chapters in Digital Health 2026, covering artificial intelligence, the bio industrial technology stack and emerging technologies.Fri, 10 Apr 2026 09:08:47 ZRoger Kuan, Ebony Christian, Apurv Gaurav, Nathanael Herz Green, PhD, Jason Novak, Sophia Poirier{45714B94-F6B3-45BA-846E-D66BCCE6E0B9}https://www.insidetechlaw.com/blog/2026/04/using-ai-in-healthcare-helping-to-stay-hipaa-compliantJeff WurzburgSusana MedeirosSusan Linda RossAbel ChackoKathleen RubinsteinBlog postArtificial intelligenceData protectionLife sciences and healthcareHealthcare providers are rapidly adopting AI for clinical and operational uses, often involving protected health information that is governed by HIPAA’s Privacy Rule.Wed, 08 Apr 2026 19:29:00 ZJeff Wurzburg, Susana Medeiros, Susan Linda Ross, Abel Chacko, Kathleen Rubinstein{7C7FDAB9-AC7D-46C4-B07C-064FE85692EF}https://www.insidetechlaw.com/blog/2023/03/biological-computing-and-related-legal-considerationsAndrea L. D'AmbraGerar MazarakisIntellectual propertyTechnologyLife sciences and healthcareBlog postArtificial intelligenceAs recent innovations in Artificial Intelligence (“AI”) such as ChatGPT ignite debate over issues such as the legal status of non-humans, privacy implications of novel computing abilities, and rights of intelligent systems’ creators over output, similar considerations confront another emerging computing field—one involving human cells.Thu, 09 Mar 2023 16:41:00 ZAndrea L. D'Ambra, Gerar Mazarakis{B34FF419-E9FE-4F7D-A8D6-655E7FF89E93}https://www.insidetechlaw.com/blog/2022/09/a-new-approach-to-referrals-under-the-eu-merger-regulationHeiko BertelmannSean MurphyAntitrust and competitionCorporateRegulationTechnologyLife sciences and healthcareBlog postThe European Commission (along with the US FTC and DOJ, UK CMA, German FCO and others), has been focused on ensuring that so-called “killer acquisitions” in the digital and life sciences sectors are reviewed. Against this background, the General Court’s decision in Illumina/Grail is of key importance to companies acquiring start-ups.Tue, 27 Sep 2022 09:06:05 ZHeiko Bertelmann, Sean Murphy{B5640BC0-5326-4FDF-B4F6-32B8F8C5C87A}https://www.insidetechlaw.com/blog/2021/08/telemedicine-ads-limited-by-facebookKate NelsonEthicsRegulationTechnologyLife sciences and healthcareBlog postAs the telemedicine industry continues to grow, especially in light of COVID-19, businesses should reconsider their policies and procedures in connection with telehealth services and user safety.Tue, 24 Aug 2021 09:51:39 ZKate Nelson